Love moves you to treat HIV.
See why SYMTUZA® may be the right treatment option for you.

Darunavir has a high barrier to drug resistance

SYMTUZA® contains darunavir, which can help you keep fighting HIV with its high barrier to HIV drug resistance. Darunavir can help stop HIV from replicating. This is why treatments containing darunavir are recommended by the Department of Health and Human Services (DHHS) Guidelines when treatment is started immediately after an HIV diagnosis.


Just one pill once a day

Once-daily SYMTUZA® is a complete prescription HIV treatment regimen in one pill. SYMTUZA® can be taken by adults and children who weigh at least 88 pounds (40 kg) who have never received HIV medicines in the past, or whose healthcare providers have determined that they meet certain requirements. It contains 800 mg darunavir/150 mg cobicistat/200 mg emtricitabine/10 mg tenofovir alafenamide fumarate. It is not known if SYMTUZA® is safe and effective in children under 18 years of age.



Weight gain and SYMTUZA®

Many people starting a new HIV treatment are concerned about gaining weight. The good news about SYMTUZA® is that no patients in a series of clinical trials stopped taking it due to weight gain, and there weren’t any new cases of Type 2 Diabetes related to SYMTUZA®. The long-term impact of SYMTUZA® on weight gain and diabetes is not known.

Some people who take protease inhibitors including SYMTUZA® can get high blood sugar, develop diabetes, or your diabetes can get worse. Tell your healthcare provider if you notice an increase in thirst or if you start urinating more often while taking SYMTUZA®.


Think about your bone and kidney health

Taking care of your bones and kidneys is an important part of your health. Some HIV treatments may negatively affect your bone and kidney health. Ask your healthcare provider about how SYMTUZA® may have less impact on your bone and kidney health than some other HIV treatments.*

The long-term impact of changes in bone health is not known.

*The other treatments in these studies were Truvada® + PREZCOBIX®, PREZISTA®/Norvir®, Evotaz®, Reyataz®/Norvir®or Kaletra®.

Talk with your healthcare provider

If you’re thinking about starting or switching HIV medications, check out the SYMTUZA® Conversation Starter. It can help you be more open and honest as you discuss treatment options with your healthcare provider, especially if you’ve forgotten doses of other medications in the past or think you might miss doses of your new treatment.


Download our Conversation Starter